245 related articles for article (PubMed ID: 28918053)
1. USH2A Gene Editing Using the CRISPR System.
Fuster-García C; García-García G; González-Romero E; Jaijo T; Sequedo MD; Ayuso C; Vázquez-Manrique RP; Millán JM; Aller E
Mol Ther Nucleic Acids; 2017 Sep; 8():529-541. PubMed ID: 28918053
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing in Patient iPSCs Corrects the Most Prevalent
Sanjurjo-Soriano C; Erkilic N; Baux D; Mamaeva D; Hamel CP; Meunier I; Roux AF; Kalatzis V
Mol Ther Methods Clin Dev; 2020 Jun; 17():156-173. PubMed ID: 31909088
[TBL] [Abstract][Full Text] [Related]
3. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.
Liu X; Lillywhite J; Zhu W; Huang Z; Clark AM; Gosstola N; Maguire CT; Dykxhoorn D; Chen ZY; Yang J
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070435
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments.
Aller E; Nájera C; Millán JM; Oltra JS; Pérez-Garrigues H; Vilela C; Navea A; Beneyto M
Eur J Hum Genet; 2004 May; 12(5):407-10. PubMed ID: 14970843
[TBL] [Abstract][Full Text] [Related]
5. The effect of the common c.2299delG mutation in USH2A on RNA splicing.
Lenassi E; Saihan Z; Bitner-Glindzicz M; Webster AR
Exp Eye Res; 2014 May; 122():9-12. PubMed ID: 24607488
[TBL] [Abstract][Full Text] [Related]
6. Natural history of Usher type 2 with the c.2299delG mutation of
Meunier A; Zanlonghi X; Roux AF; Fils JF; Caspers L; Migeotte I; Abramowicz M; Meunier I
Ophthalmic Genet; 2022 Aug; 43(4):470-475. PubMed ID: 35345973
[TBL] [Abstract][Full Text] [Related]
7. Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation.
Slijkerman RW; Vaché C; Dona M; García-García G; Claustres M; Hetterschijt L; Peters TA; Hartel BP; Pennings RJ; Millan JM; Aller E; Garanto A; Collin RW; Kremer H; Roux AF; Van Wijk E
Mol Ther Nucleic Acids; 2016 Nov; 5(10):e381. PubMed ID: 27802265
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
Pendse ND; Lamas V; Pawlyk BS; Maeder ML; Chen ZY; Pierce EA; Liu Q
Adv Exp Med Biol; 2019; 1185():91-96. PubMed ID: 31884594
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II.
Dreyer B; Brox V; Tranebjaerg L; Rosenberg T; Sadeghi AM; Möller C; Nilssen O
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273898
[TBL] [Abstract][Full Text] [Related]
10. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation.
Dreyer B; Tranebjaerg L; Brox V; Rosenberg T; Möller C; Beneyto M; Weston MD; Kimberling WJ; Cremers CW; Liu XZ; Nilssen O
Am J Hum Genet; 2001 Jul; 69(1):228-34. PubMed ID: 11402400
[TBL] [Abstract][Full Text] [Related]
11. Usher syndrome in Denmark: mutation spectrum and some clinical observations.
Dad S; Rendtorff ND; Tranebjærg L; Grønskov K; Karstensen HG; Brox V; Nilssen Ø; Roux AF; Rosenberg T; Jensen H; Møller LB
Mol Genet Genomic Med; 2016 Sep; 4(5):527-539. PubMed ID: 27957503
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum in Usher syndrome type II.
Ouyang XM; Hejtmancik JF; Jacobson SG; Li AR; Du LL; Angeli S; Kaiser M; Balkany T; Liu XZ
Clin Genet; 2004 Apr; 65(4):288-93. PubMed ID: 15025721
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.
Reiners J; Nagel-Wolfrum K; Jürgens K; Märker T; Wolfrum U
Exp Eye Res; 2006 Jul; 83(1):97-119. PubMed ID: 16545802
[TBL] [Abstract][Full Text] [Related]
14. New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome.
Major L; McClements ME; MacLaren RE
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232969
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of mutations in USH2A in British patients with Usher syndrome type II.
Leroy BP; Aragon-Martin JA; Weston MD; Bessant DA; Willis C; Webster AR; Bird AC; Kimberling WJ; Payne AM; Bhattacharya SS
Exp Eye Res; 2001 May; 72(5):503-9. PubMed ID: 11311042
[TBL] [Abstract][Full Text] [Related]
16. Analysis of intragenic USH2A copy number variation unveils broad spectrum of unique and recurrent variants.
Austin-Tse CA; Mandelker DL; Oza AM; Mason-Suares H; Rehm HL; Amr SS
Eur J Med Genet; 2018 Oct; 61(10):621-626. PubMed ID: 29655801
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: high rate of ethnicity specific mutations in Chinese USH patients.
Jiang L; Liang X; Li Y; Wang J; Zaneveld JE; Wang H; Xu S; Wang K; Wang B; Chen R; Sui R
Orphanet J Rare Dis; 2015 Sep; 10():110. PubMed ID: 26338283
[TBL] [Abstract][Full Text] [Related]
18. A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa.
Hartel BP; Löfgren M; Huygen PL; Guchelaar I; Lo-A-Njoe Kort N; Sadeghi AM; van Wijk E; Tranebjærg L; Kremer H; Kimberling WJ; Cremers CW; Möller C; Pennings RJ
Hear Res; 2016 Sep; 339():60-8. PubMed ID: 27318125
[TBL] [Abstract][Full Text] [Related]
19. A novel USH2A variant in a patient with hearing loss and prenatal diagnosis of a familial fetus: a case report.
Zhou C; Xiao Y; Xie H; Liu S; Wang J
BMC Med Genomics; 2021 Aug; 14(1):200. PubMed ID: 34376197
[TBL] [Abstract][Full Text] [Related]
20. High-efficient and precise base editing of C•G to T•A in the allotetraploid cotton (Gossypium hirsutum) genome using a modified CRISPR/Cas9 system.
Qin L; Li J; Wang Q; Xu Z; Sun L; Alariqi M; Manghwar H; Wang G; Li B; Ding X; Rui H; Huang H; Lu T; Lindsey K; Daniell H; Zhang X; Jin S
Plant Biotechnol J; 2020 Jan; 18(1):45-56. PubMed ID: 31116473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
